The Acromegaly Consensus Group considered many of the advances that have occurred in the management of acromegaly over the past 10 years. First, the growth hormone receptor antagonist pegvisomant ...

Biochemical control of acromegaly in noncured patients is usually defined as serum growth hormone (GH) levels <2.0 µg/l, plus normal-for-age serum levels of insulin-like growth factor I (IGF-I).

Colleen, from Virginia in the United States, suffers from a rare genetic condition called acromegaly or gigantism. The gene caused Charles Byrne, born in 1761 near Cookstown and known as the ...

The company is advancing its drug paltusotine, with a New Drug Application submitted for acromegaly, and preparations for a commercial launch expected by 2025. This potential milestone, along with the ...

Robert W. Baird analyst Brian Skorney maintained a Buy rating on Crinetics Pharmaceuticals (CRNX – Research Report) on November 12 and ...